Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
- 29 resultaten
Zoekresultaten
-
2024
Impact of Using the Race-Free 2021 CKD-EPI Creatinine Equation on Treatment Effects on GFR-Based End Points in Clinical Trials
Chaudhari, J., Miao, S., Lewis, J. B., Heerspink, H. J. L., Levey, A. S. & Inker, L. A., feb.-2024, In: American Journal of Kidney Diseases. 83, 2, blz. 269-272 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand3 Citaten (Scopus)69 Downloads (Pure) -
Population-Wide Screening for Chronic Kidney Disease
Mil, D. V., Heerspink, H. L. & Gansevoort, R. T., jan.-2024, In: Annals of Internal Medicine. 177, 1, blz. 117-119 3 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand39 Downloads (Pure) -
Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD
Bakker, W. M., Gansevoort, R. T., Yang, C., Chertow, G. M., Heerspink, H. J. L. & Vart, P., 29-jul.-2024, (E-pub ahead of print) In: Journal of the American Society of Nephrology.Onderzoeksoutput › Academic › peer review
-
The authors reply
Ju, W., Heerspink, H. J. L., Kretzler, M. & Bjornstad, P., mrt.-2024, In: Kidney International. 105, 3, blz. 639 1 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand15 Downloads (Pure) -
2023
Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan
Smeijer, J. D., Kohan, D. E., de Zeeuw, D. & Heerspink, H. J. L., aug.-2023, In: Diabetes, Obesity and Metabolism. 25, 8, blz. 2419-2422 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand42 Downloads (Pure) -
Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial
Vart, P., Jongs, N., Wheeler, D. C., Heerspink, H. J. L., Langkilde, A. M. & Chertow, G. M., 27-apr.-2023, In: Jama network open. 6, 4, 4 blz., E2310877.Onderzoeksoutput › Academic › peer review
Open AccessBestand3 Citaten (Scopus)21 Downloads (Pure) -
Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials
Sen, T., Curovic, V. R., Jongs, N., Laverman, G. D., Kooy, A., Persson, F., Rossing, P. & Heerspink, H. J. L., aug.-2023, In: Diabetes, Obesity and Metabolism. 25, 8, blz. 2413-2418 6 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)56 Downloads (Pure) -
Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial
Laursen, J. C., Rotbain Curovic, V., Kroonen, M. Y. A. M., Jongs, N., Zobel, E. H., Hansen, T. W., Frimodt-Møller, M., Laverman, G. D., Kooy, A., Persson, F., Heerspink, H. J. L., Hansen, C. S. & Rossing, P., okt.-2023, In: Diabetes, Obesity and Metabolism. 25, 10, blz. 3064-3067 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand2 Citaten (Scopus)131 Downloads (Pure) -
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial
Koshino, A., Oshima, M., Arnott, C., Fletcher, R. A., Bakris, G. L., Jardine, M., Mahaffey, K. W., Perkovic, V., Pollock, C., Heerspink, H. J. L. & Neuen, B. L., mei-2023, In: Diabetes, Obesity and Metabolism. 25, 5, blz. 1413-1418 6 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand3 Citaten (Scopus)97 Downloads (Pure) -
Fluid retention and heart failure in the PRECISION trial
Kohan, D. E. & Heerspink, H. J. L., 22-apr.-2023, In: The Lancet. 401, 10385, blz. 1335 1 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand2 Citaten (Scopus)89 Downloads (Pure) -
The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3
Sridhar, V. S., Heerspink, H. J. L., Davies, M. J., Banks, P., Girard, M., Garg, S. K. & Cherney, D. Z. I., jul.-2023, In: Diabetes Care. 46, 7, blz. e133-e135 3 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand3 Citaten (Scopus)54 Downloads (Pure) -
Trace element equilibrium in acute heart failure and the effect of empagliflozin
Weening, E. H., Al-Mubarak, A. A., Damman, K., Voors, A. A., van Veldhuisen, D. J., Heerspink, H. J. L., Schomburg, L., van der Meer, P. & Bomer, N., mrt.-2023, In: European Journal of Heart Failure. 25, 3, blz. 438-440 3 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)766 Downloads (Pure) -
Will SGLT2 Inhibitors Be Effective and Safe in Patients with Severe CKD, Dialysis, or Kidney Transplantation
Renal Life Cycle Trial Investigators, Heerspink, H. J. L., Berger, S. & Gansevoort, R. T., 1-nov.-2023, In: Clinical Journal of the American Society of Nephrology. 18, 11, blz. 1500-1502 3 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand8 Citaten (Scopus)67 Downloads (Pure) -
2022
Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria
DAPA CKD Trial Comm, Heerspink, H. J. L., Chertow, G. M., Jongs, N., Correa-Rotter, R., Rossing, P., Sjostrom, C. D., Langkilde, A. M. & Wheeler, D. C., nov.-2022, In: Clinical Journal of the American Society of Nephrology. 17, 11, blz. 1665-1668 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand4 Citaten (Scopus)174 Downloads (Pure) -
Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People with Type 2 Diabetes
Scholtes, R. A., Hesp, A. C., Mosterd, C. M., Geurts, F., Hoorn, E. J., Touw, D. J., Krebber, M. M., Joles, J. A., Heerspink, H. J. L. & Van Raalte, D. H., 13-dec.-2022, In: Circulation. 146, 24, blz. 1895-1897 3 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand7 Citaten (Scopus)73 Downloads (Pure) -
Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study
Sokooti, S., Flores-Guerrero, J. L., Heerspink, H. J. L., Garcia, E., Connelly, M. A., Bakker, S. J. L. & Dullaart, R. P. F., feb.-2022, In: Diabetologia. 65, 2, blz. 402-405 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand2 Citaten (Scopus)89 Downloads (Pure) -
2021
Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure
Beusekamp, J. C., Tromp, J., Boorsma, E. M., Heerspink, H. J. L., Damman, K., Voors, A. A. & van der Meer, P., jun.-2021, In: European Journal of Heart Failure. 23, 6, blz. 1049–1052 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand3 Citaten (Scopus)83 Downloads (Pure) -
Large Between-Patient Variability in eGFR Decline Before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy - A Post-Hoc Analysis From the SONAR Trial
Waijer, S., de Vries, S., Busch, R., Xie, D., Gansevoort, R., Hou, F. F., Gorriz, J., Laverman, G., De Nicola, L., Pascual, J., Provenzano, M., Pergola, P., Tang, S., Wanner, C., Zaoui, P., Parving, H.-H., de Zeeuw, D. & Heerspink, H., nov.-2021, In: Journal of the American Society of Nephrology. 32, 11, blz. 2731-2734 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand8 Citaten (Scopus)198 Downloads (Pure) -
2020
Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c
Cannon, C. P., Perkovic, V., Agarwal, R., Baldassarre, J., Bakris, G., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Heerspink, H. J. L., Jardine, M. J., Levin, A., Li, J.-W., Neal, B., Pollock, C., Wheeler, D. C., Zhang, H., Zinman, B. & Mahaffey, K. W., 4-feb.-2020, In: Circulation. 141, 5, blz. 407-410 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand108 Citaten (Scopus)92 Downloads (Pure) -
2019
Change in albuminuria as a surrogate endpoint in chronic kidney disease reply
Heerspink, H. J. L., Coresh, J., Gansevoort, R. T. & Inker, L. A., 1-mei-2019, In: Lancet Diabetes & Endocrinology. 7, 5, blz. 336-337 3 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand12 Citaten (Scopus)42 Downloads (Pure) -
2017
Effect of Linagliptin on Arterial (18)F-Fluorodeoxyglucose Positron Emission Tomography Uptake: A Randomized Controlled Trial (RELEASE)
de Boer, S. A., Heerspink, H. J. L., Lefrandt, J. D., Hovinga-de Boer, M. C., van Roon, A. M., Juárez Orozco, L. E., Glaudemans, A. W. J. M., Kamphuisen, P. W., Slart, R. H. J. A. & Mulder, D. J., 28-feb.-2017, In: Journal of the American College of Cardiology. 69, 8, blz. 1097-1098 2 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand7 Citaten (Scopus)47 Downloads (Pure) -
2016
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Parving, H.-H., Lambers-Heerspink, H. & de Zeeuw, D., 3-nov.-2016, In: New England Journal of Medicine. 375, 18, blz. 1800-1801 2 blz.Onderzoeksoutput: Letter › Academic › peer review
-
2014
A novel approach for establishing cardiovascular drug efficacy
Heerspink, H. J. L., Grobbee, D. E. & de Zeeuw, D., dec.-2014, In: Nature Reviews Drug Discovery. 13, 12, blz. 942-944 3 blz.Onderzoeksoutput › Academic › peer review
19 Citaten (Scopus) -
Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease
Lambers Heerspink, H., Gaillard, C. & Gansevoort, R., 1-jul.-2014, In: Annals of Internal Medicine. 161, 1, blz. 82-83 2 blz.Onderzoeksoutput › Academic › peer review
1 Citaat (Scopus) -
2013
Age and Sex Effects on the Single- and Multiple-dose Safety and Pharmacokinetics of the New Rennin Inhibitor ACT-178882
de Vries, D. E. & Heerspink, H. J. L., dec.-2013, In: Cardiovascular therapeutics. 31, 6, blz. E86-E87 2 blz.Onderzoeksoutput › Academic › peer review
-
2012
Effect of frozen storage on urinary concentration of kidney damage markers
Nauta, F. L., Bakker, S. J. L., Heerspink, H. L., de Zeeuw, D., van Oeveren, W., Bilo, H., de Jong, P. E. & Gansevoort, R. T., apr.-2012, In: American Journal of Kidney Diseases. 59, 4, blz. 586-589 4 blz.Onderzoeksoutput › Academic › peer review
24 Citaten (Scopus) -
Pre-renal success Reply
Lambers Heerspink, H. J., Holtkamp, F. A. & De Zeeuw, D., mrt.-2012, In: Kidney International. 81, 6, blz. 597-597 1 blz.Onderzoeksoutput › Academic › peer review
-
2011
High serum potassium levels after losartan can reflect more severe renal disease. Reply
Roscioni, S. S., Miao, Y., de Zeeuw, D. & Lambers Heerspink, H. J., nov.-2011, In: Diabetologia. 54, 11, blz. 2965-2967 3 blz.Onderzoeksoutput › Academic › peer review
3 Citaten (Scopus) -
2007
Urinary pH affects albumin concentrations after prolonged frozen storage
Brinkman, J. W., Heerspink, H. L., de Zeeuw, D., Gansevoort, R. T. & Bakker, S. J. L., dec.-2007, In: Nephrology Dialysis Transplantation. 22, 12, blz. 3670-3670 1 blz.Onderzoeksoutput › Academic › peer review
15 Citaten (Scopus)